ENTX

Entera Bio Ltd.

$1.69 +0.03 (+1.81%) At close · Jul 8

Market Cap

$83.68M

49,225,321

Press releases and events scraped from the company's investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Past events

Date	Event	Type
2026-06-15	Pre-Clinical Results for EB612: First-in-Class Oral Long-Acting PTH(1-34) Analog as Hormone Replacement Tablet for Patients with Hypoparathyroidism	Event
2026-06-14	Transforming Anabolic Treatments for Osteoporosis: New Clinical Data Supports a Single EB613 Tablet [Oral PTH(1-34)] as the Final Candidate for a Phase 3 Study	Event
2026-06-13	EB618, First-in-Class Oral Tablet of Dual GLP-1/Glucagon Receptor Agonist for Patients with Obesity and Metabolic Disorders: Results from PK-PD Study in Non-Human Primates	Event
2026-04-20	Key Opinion Leader Virtual Webinar Highlighting the Osteoporosis Treatment Landscape and the Opportunity for EB613	Event
2025-12-03	8th Annual Evercore ISI HealthCONx Conference (Fireside Chat and 1x1 Meetings)	Conference
2025-10-25	The Menopause Society 2025 Annual Meeting (Poster)	Shareholder meeting
2025-09-13	47th European Society for Clinical Nutrition & Metabolism (ESPEN) Congress (Poster)	Event
2025-09-07	American Society for Bone and Mineral Research (ASBMR) 2025 Annual Meeting (Poster and 1×1)	Shareholder meeting
2025-09-05	H.C. Wainwright 27th Annual Global Investment Conference (Presentation)	Conference
2025-09-05	American Society for Bone and Mineral Research (ASBMR) 2025 Annual Meeting (Oral Presentation)	Shareholder meeting
2025-07-13	ENDO 2025 annual meeting of the Endocrine Society	Shareholder meeting
2025-06-19	2025 BIO International Convention	Event
2025-04-13	2025 World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO)	Event
2025-04-11	2025 World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO)	Event
2025-03-12	Leerink Partners Global Healthcare Conference	Conference
2025-02-11	Oppenheimer 35th Annual Healthcare Life Sciences Conference	Conference

Source: https://investors.enterabio.com/

Key facts CIK 1638097 CUSIP M40527109 Visit website Investor relations